Amgen (AMGN) Net Margin (2009 - 2026)

Amgen (AMGN) has reported Net Margin for 18 consecutive years, with 21.11% the latest figure, recorded in Q1 2026.

• In Q1 2026, Net Margin fell 12.0% year-over-year to 21.11%; the TTM figure through Mar 2026 stood at 20.96% (up 357.0% YoY), while the FY2025 annual figure was 20.98%, up 875.0% from the prior year.
• Net Margin came in at 21.11% for Q1 2026 at Amgen, up from 13.51% in the prior quarter.
• The five-year high for Net Margin was 352.07% in Q4 2022, with the low at 1.52% in Q1 2024.
• Average Net Margin over 5 years is 40.07%, with a median of 21.11% recorded in 2026.
• Across the five-year window, Net Margin soared 32433 bps in 2022 and sank 34271 bps in 2023, its largest moves.
• Year by year, Net Margin stood at 352.07% in 2022, then slumped by 97 bps to 9.36% in 2023, then retreated by 26 bps to 6.9% in 2024, then jumped by 96 bps to 13.51% in 2025, then surged by 56 bps to 21.11% in 2026.
• According to Business Quant data, Net Margin over the past three periods registered 21.11%, 13.51%, and 33.65% for Q1 2026, Q4 2025, and Q3 2025 respectively.